Analytical Data
-
基因名
B3GAT1
- Application
-
别名
CD57; B3-GAT1; GLCATP; GlcAT-P; GlcUAT-P; HNK-1; LEU7; NK-1; Glucuronosyltransferase P; Galactosylgalactosylxylosylprotein 3-Beta-Glucuronosyltransferase 1
-
种属
Human
-
表达系统
HEK293
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q9P2W7
-
表达区间
Thr28~Ile334
-
分子量
50kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
B3GAT1, or Beta-1,3-galactosyltransferase 1, is an essential enzyme involved in the glycosylation process, specifically in the synthesis of glycosaminoglycans such as hyaluronic acid and heparin sulfate. Understanding the functional role of B3GAT1 is crucial as it has implications in various biological processes, including cell signaling, embryonic development, and tissue repair. Dysregulation of B3GAT1 expression has been linked to several diseases, including congenital disorders and cancers, highlighting its potential as a therapeutic target. Research on the recombinant version of the B3GAT1 protein allows for the detailed study of its enzymatic activity, structure-function relationships, and interaction with substrates and regulatory proteins. Additionally, these studies can facilitate a better understanding of its role in the pathophysiology of diseases and contribute to the development of novel glycan-based biomaterials for biomedical applications. By producing and characterizing recombinant B3GAT1, scientists aim to unlock insights into its biochemical pathways, paving the way for innovative strategies in disease diagnosis and treatment.
